未登录

S

Subhra Mandal

university of nebraska lincoln

H指数:27

被引数:2,312

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bipolar CD4-targeted dual-DARPin-55/57 lipid nanoparticle enables efficient CRISPR/Cas-mediated HIV-1 DNA excision and reactivation blockade in latent CD4 T cell lines

双极CD4靶向双DARPin-55/57脂质纳米颗粒能够高效介导CRISPR/Cas系统切除HIV-1 DNA并阻断潜伏CD4 T细胞系的重新激活。

Materials Today Bio

IF10.2

2026-02-150

OAAI

A long-term stable cold-chain-friendly HIV mRNA vaccine encoding multi-epitope viral protease cleavage site immunogens inducing immunogen-specific protective T cell immunity

EMERGING MICROBES & INFECTIONS

IF7.5

2024-07-182

OAAI

Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study

IF4.3

2022-06-062

OAAI

A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure Prophylaxis

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2021-03-1811

OA

Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model (vol 34, 2749, 2017)

PHARMACEUTICAL RESEARCH

IF4.3

2019-05-200

OAAI

Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2019-03-0132

OAAI

Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission

JOURNAL OF CONTROLLED RELEASE

IF11.5

2019-01-0136

OAAI

Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model

PHARMACEUTICAL RESEARCH

IF4.3

2017-09-1333

OAAI

Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect

IF4.3

2017-03-1647

OAAI

Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission

IF3.1

2017-02-2047

OAAI

An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention or Treatment of HIV Infection

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2017-01-0138

OAAI

Simultaneous quantification of tenofovir, emtricitabine, rilpivirine, elvitegravir and dolutegravir in mouse biological matrices by LC-MS/MS and its application to a pharmacokinetic study

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2016-09-0128

OAAI

Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2016-06-0134

OAAI

Polymer-Based Synthetic Dendritic Cells for Tailoring Robust and Multifunctional T Cell Responses

ACS CHEMICAL BIOLOGY

IF3.8

2014-11-1354

PREAI

Dendritic cell-based nanovaccines for cancer immunotherapy

CURRENT OPINION IN IMMUNOLOGY

IF5.8

2013-06-01123

PREAI

Therapeutic nanoworms: towards novel synthetic dendritic cells for immunotherapy

CHEMICAL SCIENCE

IF7.4

2013-01-0194

OAAI

Poly-L-lysine-Coated Silver Nanoparticles as Positively Charged Substrates for Surface-Enhanced Raman Scattering

IF3.9

2012-09-0790

PREAI

Optimization of LiCoyMn2-yO4 spinet positive electrodes for li-ion batteries by adjusting dopand and synthesis temperature

BOLETIN DE LA SOCIEDAD ESPANOLA DE CERAMICA Y VIDRIO

IF2.7

2011-03-292

OA

A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles

IF5.1

2010-01-0126

PREAI

Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study

IF5.1

2010-01-01107

PRE